十年住院湿疹病人临床资料分析

Clinical analysis of in-patients with eczema in the past decade

目的了解本科10年间住院湿疹患者的临床特点及治疗效果。方法对1994～2004年间本科收治的363例湿疹患者的一般情况皮损部位及特点、治疗方案、疗程及疗效等方面的资料进行回顾性分析。结果363例湿疹患者中男251例,女112例,男∶女=2.24∶1。年龄以46岁以上患者最多,平均61.3±12.5岁。病程从3d至40yr不等,平均57.56±111.30m。急性局限性湿疹25例(6.89%),急性泛发性湿疹31例(8.54%),亚急性湿疹2例(0.55%),慢性局限性湿疹70例(19.28%),慢性泛发性湿疹235例(64.74%)。治愈率23.42%、好转率75.75%,无效率0.83%。平均疗程19.24±13.04d。有110例患者接受系统激素治疗,口服泼尼松0.5mg/kg.d。与未接受系统激素治疗者相比,疗效并未提高,疗程无差异。结论住院湿疹病人中以老年患者居多,且多为慢性泛发性湿疹,系统使用皮质激素并不能提高疗效,缩短疗程。

Objective To study the clinical characteristics and treatment effect inpatients with eczema of our department in past decade. Methods The clinical data of in -patients with eczema in the recent ten years （ 1994 - 2004） were reviewed, the general information of patients ,the location and manifestation of lesions, the treatment methods, duration and effect were analyzed respectively. Results There were 251 male and 112 female patients among 363 patients with eczema. Male outnumbered female （ male：female, 2. 24：1 ）. The most of patients were older than 46 years old. The average age was 61.3 ± 12. 5 years old. The course of diseases was from 3 days to 40 years. The average duration was 57.56 ±111.30 months. The subtype included acute regional eczema （25 cases,6. 89% ） , acute extensive eczema （31 cases ,8.54% ） , sub -acute eczema （2 cases ,0. 55% ） , chronic regional eczema（ 70 cases, 19. 28% ） and chronic extensive eczema （235 cases,64.74% ）. The cure rate,effective rate and ineffective rate were 23.42% ,75. 75% and 0. 83% respectively. The average treatment time was 19. 24 ± 13.04 days. 110 patients were administered with systemic corticosteriods （ oral prednisone：0. 5 mg/kg · d）. However,the effective rate of these patients was not better than that of patients who were not treated with systemic corticosteriods. The treatment time was no significant difference between both groups. Conclusions The most of patients are old people among in - patients with eczema. The dominating subtype is chronic extensive eczema. It can not improve the treatment effect and shorten the treatment time with systemic corticosteriods.